{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T23:13:42Z","timestamp":1794093222570,"version":"4.8.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,11]],"date-time":"2022-10-11T00:00:00Z","timestamp":1665446400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Oncology"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.suronc.2022.101862","type":"journal-article","created":{"date-parts":[[2022,10,5]],"date-time":"2022-10-05T12:02:28Z","timestamp":1664971348000},"page":"101862","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Tumour-stroma ratio to predict pathological response to neo-adjuvant treatment in rectal cancer"],"prefix":"10.1016","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7116-4465","authenticated-orcid":false,"given":"M.T.A.","family":"Strous","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.K.E.","family":"Faes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Heemskerk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.G.P.M.","family":"Lohman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.C.G.","family":"Simons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.L.G.","family":"Janssen Heijnen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.J.","family":"Vogelaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.P.","family":"de Bru\u00efne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.suronc.2022.101862_bib1","series-title":"Dutch Guideline","year":"2008"},{"issue":"11","key":"10.1016\/j.suronc.2022.101862_bib2","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1016\/j.humpath.2011.01.015","article-title":"Predictors of tumour response after preoperative chemoradiotherapy for rectal adenocarcinomas","volume":"42","author":"Guedj","year":"2011","journal-title":"Hum. Pathol."},{"issue":"9","key":"10.1016\/j.suronc.2022.101862_bib3","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S1470-2045(10)70172-8","article-title":"Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data","volume":"11","author":"Maas","year":"2010","journal-title":"Lancet Oncol."},{"issue":"10139","key":"10.1016\/j.suronc.2022.101862_bib4","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/S0140-6736(18)31078-X","article-title":"Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch & Wait Database (IWWD): an international multicentre registry study","volume":"391","author":"van der Valk","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.suronc.2022.101862_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.radonc.2019.10.009","article-title":"The risk of distant metastases in rectal cancer managed by a watch-and-wait strategy - a systematic review and meta-analysis","volume":"144","author":"Socha","year":"2020","journal-title":"Radiother. Oncol."},{"issue":"4","key":"10.1016\/j.suronc.2022.101862_bib6","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2018.5896","article-title":"Assessment of a watch-and-wait strategy for rectal cancer in patients with a complete response after neoadjuvant therapy","volume":"5","author":"Smith","year":"2019","journal-title":"JAMA Oncol."},{"issue":"7572","key":"10.1016\/j.suronc.2022.101862_bib7","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1136\/bmj.38937.646400.55","article-title":"Diagnostic accuracy of preoperative magnetic resonance imaging in predicting curative resection of rectal cancer: prospective observational study","volume":"333","author":"Group","year":"2006","journal-title":"BMJ"},{"issue":"11","key":"10.1016\/j.suronc.2022.101862_bib8","doi-asserted-by":"crossref","first-page":"3632","DOI":"10.1007\/s00261-019-01894-8","article-title":"Diagnostic performance of magnetic resonance to assess treatment response after neoadjuvant therapy in patients with locally advanced rectal cancer","volume":"44","author":"Nahas","year":"2019","journal-title":"Abdom Radiol (NY)"},{"key":"10.1016\/j.suronc.2022.101862_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2020.101964","article-title":"How to measure tumour response in rectal cancer? An explanation of discrepancies and suggestions for improvement","volume":"84","author":"Nagtegaal","year":"2020","journal-title":"Cancer Treat Rev."},{"issue":"2","key":"10.1016\/j.suronc.2022.101862_bib10","doi-asserted-by":"crossref","first-page":"148","DOI":"10.4103\/1319-3767.178526","article-title":"Utility of rectoscopy in the assessment of response to neoadjuvant treatment for locally advanced rectal cancer","volume":"22","author":"Lopez-Lopez","year":"2016","journal-title":"Saudi J. Gastroenterol."},{"key":"10.1016\/j.suronc.2022.101862_bib11","doi-asserted-by":"crossref","DOI":"10.1038\/srep34923","article-title":"Pathological assessment of rectal cancer after neoadjuvant chemoradiotherapy: distribution of residual cancer cells and accuracy of biopsy","volume":"6","author":"Xiao","year":"2016","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.suronc.2022.101862_bib12","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s00384-011-1348-8","article-title":"Can we predict pathologic complete response before surgery for locally advanced rectal cancer treated with preoperative chemoradiation therapy?","volume":"27","author":"Kuo","year":"2012","journal-title":"Int. J. Colorectal Dis."},{"issue":"2","key":"10.1016\/j.suronc.2022.101862_bib13","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.3390\/cancers3022160","article-title":"The role of tumour stroma in colorectal cancer invasion and metastasis","volume":"3","author":"Conti","year":"2011","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.suronc.2022.101862_bib14","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s12943-019-0960-z","article-title":"Recent advances in understanding tumour stroma-mediated chemoresistance in breast cancer","volume":"18","author":"Plava","year":"2019","journal-title":"Mol. Cancer"},{"issue":"7","key":"10.1016\/j.suronc.2022.101862_bib15","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1038\/bjc.2015.81","article-title":"A distinct pre-existing inflammatory tumour microenvironment is associated with chemotherapy resistance in high-grade serous epithelial ovarian cancer","volume":"112","author":"Koti","year":"2015","journal-title":"Br. J. Cancer"},{"issue":"5","key":"10.1016\/j.suronc.2022.101862_bib16","first-page":"387","article-title":"The carcinoma-stromal ratio of colon carcinoma is an independent factor for survival compared to lymph node status and tumour stage","volume":"29","author":"Mesker","year":"2007","journal-title":"Cell. Oncol."},{"issue":"11","key":"10.1016\/j.suronc.2022.101862_bib17","first-page":"2680","article-title":"Pathologic assessment of tumour regression after preoperative chemoradiotherapy of esophageal carcinoma","volume":"73","author":"Mandard","year":"1994","journal-title":"Clinicopathologic correlations. Cancer"},{"issue":"4","key":"10.1016\/j.suronc.2022.101862_bib18","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s00428-018-2408-z","article-title":"Scoring the tumour-stroma ratio in colon cancer: procedure and recommendations","volume":"473","author":"van Pelt","year":"2018","journal-title":"Virchows Arch."},{"issue":"3","key":"10.1016\/j.suronc.2022.101862_bib19","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1093\/annonc\/mdt593","article-title":"The relationship between tumour stroma percentage, the tumour microenvironment and survival in patients with primary operable colorectal cancer","volume":"25","author":"Park","year":"2014","journal-title":"Ann. Oncol."},{"issue":"6","key":"10.1016\/j.suronc.2022.101862_bib20","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/j.1463-1318.2007.01424.x","article-title":"Pathologic response assessed by Mandard grade is a better prognostic factor than down staging for disease-free survival after preoperative radiochemotherapy for advanced rectal cancer","volume":"10","author":"Suarez","year":"2008","journal-title":"Colorectal Dis."},{"issue":"12","key":"10.1016\/j.suronc.2022.101862_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/cancers10120471","article-title":"Chemoresistance and the self-maintaining tumour microenvironment","volume":"10","author":"Yeldag","year":"2018","journal-title":"Cancers"},{"issue":"7579","key":"10.1016\/j.suronc.2022.101862_bib22","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/nature16064","article-title":"Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer","volume":"527","author":"Zheng","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.suronc.2022.101862_bib23","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.pharmthera.2016.02.008","article-title":"Cancer stem cells and chemoresistance: the smartest survives the raid","volume":"160","author":"Zhao","year":"2016","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.suronc.2022.101862_bib24","doi-asserted-by":"crossref","DOI":"10.4161\/tisb.29528","article-title":"Barriers to drug delivery in solid tumours","volume":"2","author":"Sriraman","year":"2014","journal-title":"Tissue Barriers"},{"issue":"6","key":"10.1016\/j.suronc.2022.101862_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11060862","article-title":"Cancer stem cells and radioresistance: DNA repair and beyond","volume":"11","author":"Schulz","year":"2019","journal-title":"Cancers"},{"issue":"7579","key":"10.1016\/j.suronc.2022.101862_bib26","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/nature15748","article-title":"Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance","volume":"527","author":"Fischer","year":"2015","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.suronc.2022.101862_bib27","first-page":"3387","article-title":"Hypoxia-inducible factor-1-dependent regulation of the multidrug resistance (MDR1) gene","volume":"62","author":"Comerford","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.suronc.2022.101862_bib28","first-page":"39","article-title":"The value of tumour-stroma ratio as predictor of pathologic response after neoadjuvant chemoradiotherapy in esophageal cancer","volume":"20","author":"van Pelt","year":"2020","journal-title":"Clin Transl Radiat Oncol"},{"issue":"10","key":"10.1016\/j.suronc.2022.101862_bib29","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1245\/s10434-008-9892-3","article-title":"An interval >7 weeks between neoadjuvant therapy and surgery improves pathologic complete response and disease-free survival in patients with locally advanced rectal cancer","volume":"15","author":"Tulchinsky","year":"2008","journal-title":"Ann. Surg Oncol."},{"issue":"20","key":"10.1016\/j.suronc.2022.101862_bib30","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.3748\/wjg.v12.i20.3186","article-title":"Modern management of rectal cancer: a 2006 update","volume":"12","author":"Balch","year":"2006","journal-title":"World J. Gastroenterol."},{"issue":"11","key":"10.1016\/j.suronc.2022.101862_bib31","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1634\/theoncologist.12-11-1309","article-title":"Locally advanced rectal cancer: what is the evidence for induction chemoradiation?","volume":"12","author":"Glynne-Jones","year":"2007","journal-title":"Oncol."},{"issue":"8","key":"10.1016\/j.suronc.2022.101862_bib32","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1007\/BF02234632","article-title":"Preoperative chemoradiotherapy and radical surgery for locally advanced distal rectal adenocarcinoma: pathologic findings and clinical implications","volume":"44","author":"Medich","year":"2001","journal-title":"Dis. Colon Rectum"},{"issue":"5","key":"10.1016\/j.suronc.2022.101862_bib33","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1177\/030089160509100504","article-title":"The predictive value of clinical evaluation of response to neoadjuvant chemoradiation therapy for rectal cancer","volume":"91","author":"Benzoni","year":"2005","journal-title":"Tumouri"},{"issue":"15","key":"10.1016\/j.suronc.2022.101862_bib34","doi-asserted-by":"crossref","first-page":"3475","DOI":"10.1200\/JCO.2005.06.114","article-title":"Clinical examination following preoperative chemoradiation for rectal cancer is not a reliable surrogate end point","volume":"23","author":"Guillem","year":"2005","journal-title":"J. Clin. Oncol."},{"issue":"8","key":"10.1016\/j.suronc.2022.101862_bib35","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.ejso.2018.04.008","article-title":"Clinical lymph node staging in colorectal cancer; a flip of the coin?","volume":"44","author":"Brouwer","year":"2018","journal-title":"Eur. J. Surg. Oncol."},{"issue":"2","key":"10.1016\/j.suronc.2022.101862_bib36","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/DCR.0b013e31827541e2","article-title":"Distribution of residual cancer cells in the bowel wall after neoadjuvant chemoradiation in patients with rectal cancer","volume":"56","author":"Duldulao","year":"2013","journal-title":"Dis. Colon Rectum"},{"issue":"3","key":"10.1016\/j.suronc.2022.101862_bib37","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.ejca.2010.09.043","article-title":"Reproducibility and validation of tumour stroma ratio scoring on oesophageal adenocarcinoma biopsies","volume":"47","author":"Courrech Staal","year":"2011","journal-title":"Eur. J. Cancer"},{"issue":"1","key":"10.1016\/j.suronc.2022.101862_bib38","first-page":"13","article-title":"Optimal interval to surgery after neoadjuvant chemoradiotherapy in rectal cancer: a systematic review and meta-analysis","volume":"17","author":"Du","year":"2018","journal-title":"Clin. Colorectal Cancer"}],"container-title":["Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960740422001578?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960740422001578?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T03:21:28Z","timestamp":1760757688000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960740422001578"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":38,"alternative-id":["S0960740422001578"],"URL":"https:\/\/doi.org\/10.1016\/j.suronc.2022.101862","relation":{},"ISSN":["0960-7404"],"issn-type":[{"value":"0960-7404","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tumour-stroma ratio to predict pathological response to neo-adjuvant treatment in rectal cancer","name":"articletitle","label":"Article Title"},{"value":"Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.suronc.2022.101862","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101862"}}